CHRU Montpellier - Hopital Saint-Eloi

Montpellier 34295 Cedex 5

0 studies enrolling now · 4 studies all time

What they study most

Colitis, Ulcerative, Crohn Disease, Crohn's Disease

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease — Completed